Olema Pharmaceuticals
(NASDAQ) OLMA
Olema Pharmaceuticals Financials at a Glance
Market Cap
$1.44B
Revenue (TTM)
$0.00
Net Income (TTM)
$162.45M
EPS (TTM)
$-1.86
P/E Ratio
-8.84
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$16.70
Volume
109,153.73
Open
$16.78
Price
$16.70
Volume
109,153.73
Open
$16.78
Previous Close
$16.48
Daily Range
$16.38 - $16.89
52-Week Range
$3.89 - $36.26
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$16.70
Volume
109,153.73
Open
$16.78
Previous Close
$16.48
Daily Range
$16.38 - $16.89
52-Week Range
$3.89 - $36.26
OLMA News
OLMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Olema Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
131
CEO
Sean P. Bohen, MD, PhD
Website
www.olema.comHeadquarters
San Francisco, CA 94107, US
OLMA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-37%
Return on Capital
-37%
Return on Assets
-30%
Earnings Yield
-11.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.44B
Shares Outstanding
87.16M
Volume
109.15K
Short Interest
0.00%
Avg. Volume
1.59M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$178.70M
EBITDA
$178.21M
Operating Cash Flow
$146.72M
Capital Expenditure
$0.00
Free Cash Flow
$146.72M
Cash & ST Invst.
$505.44M
Total Debt
$1.19M
Olema Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$187.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.44B
N/A
Market Cap/Employee
$14.96M
N/A
Employees
96
N/A
Net Income
$46.06M
-37.2%
EBITDA
$49.90M
-36.1%
Quarterly Fundamentals
Net Cash
$504.24M
+16.5%
Accounts Receivable
$4.06M
+91.3%
Inventory
$0.00
N/A
Long Term Debt
$69.00K
-73.2%
Short Term Debt
$1.12M
-4.1%
Return on Assets
-30.45%
N/A
Return on Invested Capital
-37.10%
N/A
Free Cash Flow
$38.33M
-45.8%
Operating Cash Flow
$38.33M
-45.8%